Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.
暂无分享，去创建一个
P. Fasching | D. Provencher | I. Ray-Coquard | P. Haluska | P. Cottu | G. Konecny | B. Winterhoff | L. Roman | J. Glaspy | D. Slamon | A. Rody | S. Mahner | A. W. Hendrickson | M. Poelcher | B. Karlan | T. Davidson | S. Mullany | J. Sehouli | G. Feisel-Schwickardi | H. Chen | S. Ma | A. Yachnin